pd 98059 has been researched along with Prostatic Hyperplasia in 1 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, K | 1 |
| Pascal, LE | 1 |
| Li, F | 1 |
| Chen, W | 1 |
| Dhir, R | 1 |
| Balasubramani, GK | 1 |
| DeFranco, DB | 1 |
| Yoshimura, N | 1 |
| He, D | 1 |
| Wang, Z | 1 |
1 other study available for pd 98059 and Prostatic Hyperplasia
| Article | Year |
|---|---|
Tight junction protein claudin-1 is downregulated by TGF-β1 via MEK signaling in benign prostatic epithelial cells.
Topics: Cell Line; Claudin-1; Down-Regulation; Epithelial Cells; Flavonoids; Gene Knockdown Techniques; Huma | 2020 |